Immediate Impact

1 by Nobel laureates 10 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2023 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
1 intermediate paper

Works of G Leigheb being referenced

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
2008

Author Peers

Author Last Decade Papers Cites
G Leigheb 147 147 45 186 42 491
J.‐H. Saurat 120 190 37 161 31 532
Cristina Guerriero 105 139 23 109 47 463
L. Stankler 124 189 60 99 44 527
Erin Boh 124 131 42 135 45 574
Antonio Zambrano 108 188 132 159 57 532
Monika Kapińska-Mrowiecka 126 99 18 294 27 538
A Salerno 79 91 37 262 40 566
Eija Johansson 133 108 46 119 40 493
Cristina Galache 146 179 47 137 56 482
David H. Ciocon 59 209 38 150 42 427

All Works

Loading papers...

Rankless by CCL
2026